We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CHSYF market cap is 2.28B. The company's latest EPS is CNY 0.9792 and P/E is 0.95.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 6.07B | 6.95B | 8.34B | 9.15B | 8.01B |
| Operating Income | 2.51B | 2.74B | 3.27B | 3.65B | 2.94B |
| Net Income | 1.96B | 2.53B | 3.02B | 3.26B | 2.4B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 11.17B | 12.7B | 15.81B | 17.75B | 17.73B |
| Total Liabilities | 1.65B | 1.6B | 2.96B | 3.02B | 2.17B |
| Total Equity | 9.52B | 11.1B | 12.85B | 14.74B | 15.56B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 2.56B | 2.69B | 2.49B | 3.55B | 2.5B |
| Investing | -309.39M | -353.82M | -1.52B | -1.18B | -442.28M |
| Financing | -1.7B | -1.03B | -258.39M | -1.4B | -2.13B |
| Market Cap | 2.28B |
| Price to Earnings Ratio | 0.95 |
| Price to Sales Ratio | 0.28 |
| Price to Cash Ratio | 0.53 |
| Price to Book Ratio | 0.15 |
| Dividend Yield | - |
| Shares Outstanding | 2.45B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 60 |
| 52 Week Change | -36.25% |
| 52 Week High | 1.518 |
| 52 Week Low | 0.9307 |
| Spread (Intraday) | 0.11 (11.6%) |
| Company Name | China Medical System Holdings Ltd (PK) |
| Address |
maples corporate services limited grand cayman KY1-1104 |
| Website | https://www.cms.net.cn |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
